1. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011
2. Effects of sustained virological response (SVR) on the risk of liver transplant, hepatocellular carcinoma, death and re-infection: meta-analysis of 129 studies in 23,309 patients with hepatitis C infection;Saleem;Hepatology,2014
3. AASLD/IDSA/IAS–USA. Recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.org. Accessed April 24, 2014.
4. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C;Gane;N Engl J Med,2013
5. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial;Osinusi;JAMA,2013